Published in Proc Eur Dial Transplant Assoc on January 01, 1979
Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature (1999) 3.93
Ragweed hay fever: genetic control and linkage to HL-A haplotypes. Science (1972) 3.43
Intussusception in adults. Ann Surg (1970) 3.42
Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement. J Exp Med (1974) 3.38
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med (2001) 3.16
The effect of race on access and outcome in transplantation. N Engl J Med (1991) 2.98
In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci U S A (1993) 2.39
A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med (1994) 2.22
Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. JAMA (1974) 1.92
Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. N Engl J Med (1979) 1.83
Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med (1996) 1.82
A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells. J Exp Med (1990) 1.80
Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins. J Exp Med (1991) 1.78
Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis (1998) 1.77
Viral syndromes and renal homograft rejection. Ann Surg (1972) 1.74
Disease associations of the Ia-like human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus. J Exp Med (1978) 1.71
Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis. N Engl J Med (1975) 1.66
Evidence for the association of unexplained pulmonary hypertension in children with the major histocompatibility complex. Circulation (1992) 1.54
Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kidney Dis (1997) 1.48
Shared HLA antigens and reproductive performance among Hutterites. Am J Hum Genet (1983) 1.47
Micromethod for rapid separation of lymphocytes from peripheral blood. Ann Clin Lab Sci (1973) 1.44
Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families. J Exp Med (1975) 1.40
Collagen as a biomaterial. Annu Rev Biophys Bioeng (1974) 1.40
Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols. Transplantation (1993) 1.39
Milk safety. Science (1994) 1.38
Ocular complications in renal transplant recipients. Am J Med (1973) 1.38
Hydroxyl radical scavengers inhibit lymphocyte mitogenesis. Proc Natl Acad Sci U S A (1982) 1.36
Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun (1995) 1.33
Sounding board: Effective primary care by the subspecialty center. N Engl J Med (1975) 1.32
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
Alpha-2-globulins in renal graft rejection. Effects of in vitro lymphocyte function. Transplantation (1969) 1.29
In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine. Transplantation (1998) 1.29
Cytomegalovirus infections with viremia following renal transplantation. Arch Intern Med (1971) 1.24
Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med (2001) 1.22
Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate. J Immunol (1984) 1.20
Ototoxicity induced by furosemide. N Engl J Med (1970) 1.19
Generation of a lymphocyte growth factor by treatment of human cells with neuraminidase and galactose oxidase. J Exp Med (1980) 1.18
Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest (1989) 1.15
Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type. Clin Immunol Immunopathol (1982) 1.15
Selective suppression by adherent cells, prostaglandin, and cyclic AMP analogues of blastogenesis induced by different mitogens. J Immunol (1979) 1.14
Rheumatic fever-associated B cell alloantigens as identified by monoclonal antibodies. Arthritis Rheum (1985) 1.13
The nitroblue-tetrazolium test. Usefulness in detecting bacterial infections in uraemic and immunosuppressed renal transplant patients. Lancet (1972) 1.11
Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization. J Immunol (1984) 1.10
Demonstration of a direct inhibitory effect of cyclosporine on normal human T-cells with two novel models of T-cell activation as probes. Cell Immunol (1989) 1.09
Hypercalcemia after renal transplantation. Long-term follow-up data. N Engl J Med (1973) 1.09
Impaired fc-mediated mononuclear phagocyte system clearance in HLA-DR2 and MT1-positive healthy young adults. J Exp Med (1983) 1.09
Progressive state selection of cells in low serum promotes high density growth and neoplastic transformation in NIH 3T3 cells. Cancer Res (1990) 1.08
Hydroxyl radical scavengers inhibit human natural killer cell activity. Nature (1984) 1.08
Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child. Cancer (1983) 1.08
Dermatologic evaluation of pruritus in patients on hemodialysis. N Y State J Med (1973) 1.08
Hypocalcemia following bilateral nephrectomy. Urology (1973) 1.07
Lack of association of histocompatibility antigens with primary open-angle glaucoma. Arch Ophthalmol (1978) 1.07
Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int (1988) 1.05
HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients. J Immunol (1998) 1.05
Histocompatibility (HL-A) antigens and primary open-angle glaucoma. Tissue Antigens (1976) 1.05
Plasma prorenin and renin in anephric patients. Circ Res (1977) 1.04
Inhibition of lymphocyte transformation by a placental glycoprotein. Transplantation (1971) 1.04
Optimization of RNA yield, purity and mRNA copy number by treatment of urine cell pellets with RNAlater. J Immunol Methods (2003) 1.03
The influence of pulsatile preservation on renal transplantation in the 1990s. Transplantation (2000) 1.01
TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension (1999) 1.01
Molecular executors of cell death--differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation (1996) 1.00
Surgical cure of hypoglycemia associated with cystosarcoma phyllodes and elevated nonsuppressible insulin-like protein. Am J Med (1983) 0.99
The HLA system in the families of patients with juvenile diabetes mellitus. J Exp Med (1976) 0.98
HLA-A28 and steroid-induced diabetes in renal transplant patients. JAMA (1980) 0.98
Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int (1996) 0.98